The effect of drug lipophilicity on P-glycoprotein-mediated colchicine efflux at the blood-brain barrier

被引：0
|
作者：
Khan, EU [1 ]
Reichel, A
Begley, DJ
Roffey, SJ
Jezequel, SG
Abbott, NJ
机构：
[1] Univ London Kings Coll, Dept Physiol, London WC2R 2LS, England
[2] Pfizer, Sandwich, Kent, England
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 1998年 / 36卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：84 / 86
页数：3
相关论文
共 50 条
  • [1] P-glycoprotein-mediated efflux transport of anticancer drugs at the blood-brain barrier
    Tsuji, A
    THERAPEUTIC DRUG MONITORING, 1998, 20 (05) : 588 - 590
  • [2] Blood-Brain Barrier Transport of Naloxone Does Not Involve P-glycoprotein-Mediated Efflux
    Suzuki, Toyofumi
    Miyata, Mariko
    Zaima, Chika
    Furuishi, Takayuki
    Fukami, Toshiro
    Kugawa, Fumihiko
    Tomono, Kazuo
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (01) : 413 - 421
  • [3] P-glycoprotein-mediated efflux of phenobarbital at the blood-brain barrier evidence from transport experiments in vitro
    Yang, Zhi-Hong
    Liu, Xiao-Dong
    EPILEPSY RESEARCH, 2008, 78 (01) : 40 - 49
  • [4] Retrospective Analysis of P-Glycoprotein-Mediated Drug-Drug Interactions at the Blood-Brain Barrier in Humans
    Sugimoto, Hiroshi
    Hirabayashi, Hideki
    Amano, Nobuyuki
    Moriwaki, Toshiya
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (04) : 683 - 688
  • [5] P-glycoprotein-mediated transport of itraconazole across the blood-brain barrier
    Miyama, T
    Takanaga, H
    Matsuo, H
    Yamano, K
    Yamamoto, K
    Iga, T
    Naito, M
    Tsuruo, T
    Ishizuka, H
    Kawahara, Y
    Sawada, Y
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) : 1738 - 1744
  • [6] Do P-glycoprotein-mediated drug-drug interactions at the blood-brain barrier impact morphine brain distribution?
    Guelave, Berfin
    Lesmana, Ariel
    de Lange, Elizabeth C. M.
    van Hasselt, J. G. Coen
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2025, 52 (01)
  • [7] High brain distribution of a new central nervous system drug candidate despite its P-glycoprotein-mediated efflux at the mouse blood-brain barrier
    Taccola, Camille
    Cartot-Cotton, Sylvaine
    Valente, Delphine
    Barneoud, Pascal
    Aubert, Catherine
    Boutet, Valerie
    Gallen, Fabienne
    Lochus, Murielle
    Nicolic, Sophie
    Dodacki, Agnes
    Smirnova, Maria
    Cisternino, Salvatore
    Decleves, Xavier
    Bourasset, Fanchon
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 117 : 68 - 79
  • [8] P-glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier:: evidence from microdialysis experiments in rats
    Potschka, H
    Fedrowitz, M
    Löscher, W
    NEUROSCIENCE LETTERS, 2002, 327 (03) : 173 - 176
  • [9] Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice
    Alhaddad, Hisham
    Cisternino, Salvatore
    Decleves, Xavier
    Tournier, Nicolas
    Schlatter, Joel
    Chiadmi, Fouad
    Risede, Patricia
    Smirnova, Maria
    Besengez, Capucine
    Scherrmann, Jean-Michel
    Baud, Frederic J.
    Megarbane, Bruno
    CRITICAL CARE MEDICINE, 2012, 40 (12) : 3215 - 3223
  • [10] RESPIRATORY TOXICITY OF BUPRENORPHINE RESULTS FROM THE BLOCKAGE OF P-GLYCOPROTEIN-MEDIATED EFFLUX OF NORBUPRENORPHINE AT THE BLOOD-BRAIN BARRIER IN MICE
    Megarbane, B.
    Alhaddad, H.
    Cistemino, S.
    Risede, P.
    Baud, F. J.
    INTENSIVE CARE MEDICINE, 2012, 38 : S208 - S208
12345